Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.

IF 2.2 4区 医学 Q2 DERMATOLOGY Australasian Journal of Dermatology Pub Date : 2024-11-21 DOI:10.1111/ajd.14386
Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, H Miles Prince
{"title":"Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.","authors":"Harmeet K Bhullar, Friyana Bhabha, Chris McCormack, H Miles Prince","doi":"10.1111/ajd.14386","DOIUrl":null,"url":null,"abstract":"<p><p>Sneddon-Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65-year-old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australasian Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ajd.14386","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Sneddon-Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65-year-old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿卡鲁替尼使斯内登-威尔金森病的皮肤症状完全缓解。
斯内登-威尔金森(SW)病是一种罕见的疾病,通常发生在单克隆免疫球蛋白的背景下,治疗方案尚未得到充分研究。我们在此介绍一例 65 岁女性 SW 患者,她患有淋巴浆细胞性淋巴瘤(LPL)并伴有 IgA 副蛋白,但病情并不严重,在服用布鲁顿酪氨酸激酶抑制剂(BTKi)阿卡鲁替尼后,皮肤症状完全缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.20
自引率
5.00%
发文量
186
审稿时长
6-12 weeks
期刊介绍: Australasian Journal of Dermatology is the official journal of the Australasian College of Dermatologists and the New Zealand Dermatological Society, publishing peer-reviewed, original research articles, reviews and case reports dealing with all aspects of clinical practice and research in dermatology. Clinical presentations, medical and physical therapies and investigations, including dermatopathology and mycology, are covered. Short articles may be published under the headings ‘Signs, Syndromes and Diagnoses’, ‘Dermatopathology Presentation’, ‘Vignettes in Contact Dermatology’, ‘Surgery Corner’ or ‘Letters to the Editor’.
期刊最新文献
Australasian hidradenitis suppurativa management guidelines. Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib. Expression of JAK/STAT signalling in bullous pemphigoid. Is tofacitinib monotherapy also effective for the treatment of Acrodermatitis continua of Hallopeau? Melanomas on the dorsum of the hand are extremely rare: A series of seven cases with clinical and dermatoscopic images.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1